There's obviously bound to be 'medical' and comfort reasons over disposable ones beyond the disposable society, but the cynic in me can't help but feel that research into longer-lasting more-comfortable reusable contacts would be taken through to market in preference to a more profitable cheaper-made daily product.
- don't accumulate gunk over days/weeks/months that can cause injury and/or infection
- are cheap to replace if torn or lost (which happens with tiny transparent things)
- are made from softer, thinner material (because it doesn't need to last) which is way more comfortable
Permanent lenses had also led to some blood vessel overgrowth due to lack of oxygenation.
Using a new pair everyday does make quite a few tricky problems go away downside being slight extra cost and extra plastic pollution.
FWIW, this no longer appears to be the case. New "extended-wear" contacts have excellent oxygen permeability, and my ophthalmologist hasn't noticed any overgrowth of capillaries/vessels over the past 15 years of me wearing them. You can also sleep in them now, and I find them more comfortable than dailies actually, due to their high permeability.
Meanwhile on the monthly side of things, contacts that are approved for "extended wear" have enough oxygen permeability to be worn overnight now. Ten years ago, this was for up to 7-14 days (Biofinity), now they are up to 30 days (Air Optix Night & Day). This also greatly reduces the chance of infection (because you're not handling the contact 60 times per month) and is just super convenient because it's nice only having to touch your eye 12 times per year - you largely forget you're even shortsighted at all because you can see clearly from the moment you wake up till the moment you fall asleep every single day.
If anything, I'd argue that the monthly ones are the "scam" pricing, not the daily ones. They're priced just about the same per year, but the manufacturing costs must be significantly lower when you're only consuming 1/30th the number of units.
Regardless, the market appears to support ongoing R&D for both strategies.